Over the past decade, the ups and downs, situation changes. The next decade, what we will encounter problems? What should be moving in the direction of development?
Years old and the new intersection at the moment, our eyes to the future, explore the possibilities of the next decade. Our country’s future will be in what direction? Every citizen of another country are looking forward to what the fate of their own?
Every one will have a different answer, everyone will have different expectations of the direction we want to through a different perspective, a different depth, try to make inquiry on the future development:
From the social elite, to the most ordinary Chinese citizens, their expectations, they see the future, if your are thinking fit? What is your expectation?
About to pull the curtain, the new era is at hand. We look forward to work together for their own.
Whether you recognize or not recognize the worth mentioning. We have been standing on the threshold of a new. The new century’s first 10 years have passed, the next 10 years is at hand.
In the past 10 years, China has us in 2000 did not anticipate changes. The next decade, we will face what the future? This is an open question, the future will follow our path and direction of the unknown continue.
But, after all, human history is created by people, is driving people constantly choose the course of history. China, of course, the next ten years the choice of the decision by the Chinese people, not a one or a number of Chinese people, but every Chinese.
Yes, it is your choice, not the other determines how we look at 2020, the past decade. As we look back, all changes are up to you to promote the formation of my choice.
Our carefully selected elite and grassroots, all from different directions expressed their expectations for the future – it is their future efforts.
What we need now is you to join us come with us to promote the direction of Chinese history.
Golden age is before us in 2010, the new decade sail! Target 2020, we embark on a new journey together.
July 12, 2009
Send text messages every year, a phone call than a convenience. Forwarding other people’s messages and I really lost were the things that point the total use of a mind to Zhaomaohuahu essays, considered one of respect for everyone. SMS, short and pithy, but also very use of mind, from this year, on the record here it can be regarded as an accountable!
The Taoist riding on a cow, bull;
Zhao public cross tiger, tiger.
I extend to you Changsha feet Hogye 3 Xiao:
Xiao country home of a good good body good
2 Xiao Yun major cause of large fortune,
Issued shares of the three tsunami-based hair passions hair.
Oh, not bad, right?
July 7, 2009
Struck again to make global influenza vaccine preventable diseases of mankind, the most effective weapons increasingly a concern. According to statistics, in 2008, global vaccine production capacity to 19.2 billion U.S. dollars, and is expected to increase in 2013 to 390 million. China is the world’s largest vaccine producer, is the world’s vaccine production companies than any other country, but Chinese vaccine in 2008 annual revenues of the pharmaceutical industry accounted for the proportion of total income was less than 0.73% of the companies working in this area and investment institutions , this means a huge room for growth.
Vaccine development stage and trend
According to the classification of different vaccines can be divided into several categories, commonly used technology is based on the development of vaccines and new vaccines into the traditional vaccine.
Traditional vaccines, typically reduce the toxicity of the pathogenic virus, the virus is small or death to the virus to the human immune system to produce antibodies against the virus, which produce antibodies in the body defense, thus preventing viruses. Traditional vaccines can be divided into live attenuated vaccines, inactivated vaccines and subunit vaccines, with full immunity, and the advantages of low manufacturing cost, is still occupy a large market share.
New vaccines or vaccines based on genetic engineering vaccine of high-tech as the main, including: genetic engineering vaccines (genetic engineering subunit vaccines, genetic engineering vector vaccine, DNA vaccine, gene deletion live vaccines and protein engineering vaccines), genetic recombination vaccines, synthetic peptide vaccines, anti-idiotypic antibody vaccines, and micro-capsules controlled release vaccines. New vaccine has good safety and specific function of strong, high purity of the product advantages, which is a very rapid pace.
Global vaccine market competition
1. Market Capacity
In 2008, global vaccine production capacity to 19.2 billion U.S. dollars 2004-2008, the vaccine industry’s annual compound growth rate of 25.1%. By 2013, global vaccine industry market size will reach 39 billion U.S. dollars. In 2008 the domestic market the vaccine industry to 60 billion yuan from 3.1 billion in 2006, rapid growth, the annual compound growth rate of 39%, our vaccine pharmaceutical industry revenue in 2008, less than 0.73% of total revenue, which means the next great room for growth (source: CITIC Securities).
2. The world’s leading manufacturers
Because the vaccine is the inoculation of healthy people to produce immunity, so its safety and side effects of more people’s attention. Vaccine manufacturers usually are subject to the host government or professional organizations, the strict regulation, market concentration is very high. Currently, there are 20 global
World Health Organization, more than businesses were identified as vaccine manufacturers, in fact, GlaxoSmithKline (DPT triple vaccine), Merck (Gardasil cervical cancer vaccine, etc.), Wyeth (pneumococcal vaccine), Sanofi-Aventis (spinal cord gray matter go far) and Novatis top five manufacturers account for more than 80% of the global vaccine market.
3. Chinese vaccine manufacturers and the competitive landscape situations
China is the world’s Zuitai vaccine producer, is the world’s largest vaccine production Guo Jia Qi Ye annual output of 1 billion servings vaccine, vaccine types and Shu Liang also reached the world of the most, Qi Zhong Yu Fang for hepatitis B, polio, measles , whooping cough, diphtheria, tetanus vaccine production pediatric common disease of 5 million copies, have been fully achieve planned immunization.
China’s health care system as the structure and management of EPI vaccine market is divided into the vaccine market and with the market price of the vaccine, commonly known as “program” and “plan”, roughly 7:3. EPI vaccine procurement by the government tender, low cost, and profits are high, the market is basically stable, the key supplied by the domestic vaccine production. A bivalent vaccine is not included in the national immunization areas, vaccination vaccine voluntarily choose their own expense. Inoculated by consumers at their own expense, such vaccines are expensive, high profit margins. Including the recent expanded use of vaccines for children and adults, as well as for specific groups of rabies vaccine, epidemic hemorrhagic fever vaccine. Scheme, the basic vaccines by the GlaxoSmithKline, Sanofi-Aventis, Novartis and other international giants control. Pattern of domestic competition in the Health Group for the six Institute (Beijing, Lanzhou, Changchun, Wuhan, Shanghai, Chengdu) and Kunming, the long-term in Medical industry occupies a dominant position, other enterprises to actively participate.
The challenge, the vaccine industry can not stop forward progress
1. Production of regulatory policies adopted measures,
2. The national immunization program growing species
3. Investment M & Events
4. On the VC / PE investment in the vaccine industry view point
As in recent years, avian flu, swine flu and other epidemics have erupted, the eyes of unwitting investors focused on the vaccine industry. Indeed, the vaccine industry has a very good profit margins and prospects, but this depends on many preconditions.
The vaccine industry, what is most important? Security! Vaccine batch release promulgated by the state policy and the production process involving industry, storage and transportation and other aspects of the control means, is to ensure maximum safety. To ensure safety, the state in violation of relevant provisions of the vaccine production and circulation enterprises, more and more stringent penalties, have been due to poor packaging as counterfeit drugs, there are sets of approval because of adverse events and other reasons have been ordered to stop production and cancellation of permit card. An adverse event is often a company will seriously affect the sales of one to several years, and even lead to a business he never rose again.
Health
Care Investment areas that voted to back a vaccine development company legality of the product to see whether there is good variety, not much variety of future reserves, the market and so much space, I would like to emphasize that the vaccine companies must cast a look at the enterprises have annual industry experience with a professional team. Professional R & D team to make the future development of new strains and new product development and secure, experienced professional production, monitoring teams to ensure production of high quality, safe products, not professional managers can switch to alternative, which is the of survival, courage to make our investment funds, a prerequisite for investment decisions.
July 4, 2009